|Articles|April 21, 2022

Veeva Vault CTMS Launches at Bristol Myers Squibb

Updated CTMS streamlines trial management to speed medicines to patients.

Veeva Systems announced that Bristol Myers Squibb has implemented Veeva Vault CTMS globally to drive end-to-end trial management. The new CTMS replaced a heritage Celgene CTMS and a heritage Bristol Myers Squibb CTMS and is tightly integrated with Veeva’s eTMF and Study Startup applications. The total implementation time was less than 20 months.

Read more about the launch here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content